Zydus Cadila gets USFDA nod for generic muscle spasm treatment tablets

Zydus Cadila gets USFDA nod for generic muscle spasm treatment tablets The company has received final approval from the United States Food and Drug Administration (USFDA) to market Baclofen tablets in the strengths of 10 mg and 20 mg, Zydus Cadila said in a filing to BSE.

No comments:

Post a Comment